Postural Orthostatic Tachycardia Syndrome (POTS) – A Review of Pathophysiological Mechanisms, Diagnosis and Therapy
DOI:
https://doi.org/10.12775/JEHS.2024.71.56193Keywords
postural orthostatic tachycardia syndrome, POTS, diagnosis, treatment, pathophysiologyAbstract
Introduction
Postural Orthostatic Tachycardia Syndrome (POTS) is a chronic disorder of the autonomic nervous system. It is characterized by orthostatic tachycardia and orthostatic intolerance upon standing, without low blood pressure. It affects multiple body systems, leading to a wide range of symptoms that contribute to debilitation and reduced functionality. The disorder has significant functional and economic consequences, although its underlying mechanisms remain only partially understood. Many POTS patients receive inadequate care due to limited understanding of the etiology of POTS, a lack of evidence-based treatment options, and minimal training among physicians in recognizing and managing POTS.
Aim of the study
The purpose of this review is to provide a comprehensive overview of POTS, including its etiology, associated comorbidities, diagnostic challenges, and approaches to diagnosis, as well as potential pharmacological and non-pharmacological treatment options.
Material and Method
The literature search methodology involved using the keyword "POTS" in combination with terms such as "etiology," "treatment," "diagnosis," "symptoms," "long COVID-19," and "exercise." Searches were conducted in the PubMed and Google Scholar databases, focusing primarily on review articles and clinical trials.
Conclusions
Raising awareness of POTS among physicians is essential for delivering optimal healthcare to patients. Despite the prevalence of POTS and its significant impact on patients' lives, research funding remains disproportionately low. Strengthening research infrastructure is crucial to understand the pathophysiology of POTS and to standardize evaluation tools, outcome measures, and patient care.
References
Olshansky B, Cannom D, Fedorowski A, Stewart J, Gibbons C, Sutton R, Shen WK, Muldowney J, Chung TH, Feigofsky S, Nayak H, Calkins H, Benditt DG. Postural Orthostatic Tachycardia Syndrome (POTS): A critical assessment. Prog Cardiovasc Dis. 2020 May-Jun;63(3):263-270. doi: 10.1016/j.pcad.2020.03.010. Epub 2020 Mar 25. PMID: 32222376; PMCID: PMC9012474.
Fedorowski A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management. J Intern Med. 2019 Apr;285(4):352-366. doi: 10.1111/joim.12852. Epub 2018 Nov 23. PMID: 30372565.
Vernino S, Bourne KM, Stiles LE, Grubb BP, Fedorowski A, Stewart JM, Arnold AC, Pace LA, Axelsson J, Boris JR, Moak JP, Goodman BP, Chémali KR, Chung TH, Goldstein DS, Diedrich A, Miglis MG, Cortez MM, Miller AJ, Freeman R, Biaggioni I, Rowe PC, Sheldon RS, Shibao CA, Systrom DM, Cook GA, Doherty TA, Abdallah HI, Darbari A, Raj SR. Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1. Auton Neurosci. 2021 Nov;235:102828. doi: 10.1016/j.autneu.2021.102828. Epub 2021 Jun 5. PMID: 34144933; PMCID: PMC8455420.
Vasavada AM, Verma D, Sheggari V, Ghetiya S, Chirumamilla PC, Kotak RA, Mahapatra SS, Patel T, Jain M. Choices and Challenges With Drug Therapy in Postural Orthostatic Tachycardia Syndrome: A Systematic Review. Cureus. 2023 May 11;15(5):e38887. doi: 10.7759/cureus.38887. PMID: 37313107; PMCID: PMC10259876.
Knoop I, Picariello F, Jenkinson E, Gall N, Chisari C, Moss-Morris R. Self-reported symptom burden in postural orthostatic tachycardia syndrome (POTS): A narrative review of observational and interventional studies. Auton Neurosci. 2023 Jan;244:103052. doi: 10.1016/j.autneu.2022.103052. Epub 2022 Nov 18. PMID: 36525900.
Feigofsky S, Fedorowski A. Defining Cardiac Dysautonomia - Different Types, Overlap Syndromes; Case-based Presentations. J Atr Fibrillation. 2020 Jun 30;13(1):2403. doi: 10.4022/jafib.2403. PMID: 33024503; PMCID: PMC7533131.
Thieben MJ, Sandroni P, Sletten DM, Benrud-Larson LM, Fealey RD, Vernino S, Lennon VA, Shen WK, Low PA. Postural orthostatic tachycardia syndrome: the Mayo clinic experience. Mayo Clin Proc. 2007 Mar;82(3):308-13. doi: 10.4065/82.3.308. PMID: 17352367.
Jacob G, Costa F, Shannon JR, Robertson RM, Wathen M, Stein M, Biaggioni I, Ertl A, Black B, Robertson D. The neuropathic postural tachycardia syndrome. N Engl J Med. 2000 Oct 5;343(14):1008-14. doi: 10.1056/NEJM200010053431404. PMID: 11018167.
Gibbons CH, Bonyhay I, Benson A, Wang N, Freeman R. Structural and functional small fiber abnormalities in the neuropathic postural tachycardia syndrome. PLoS One. 2013 Dec 27;8(12):e84716. doi: 10.1371/journal.pone.0084716. PMID: 24386408; PMCID: PMC3874039.
Qu HQ, Hakonarson H. Navigating Complexity in Postural Orthostatic Tachycardia Syndrome. Biomedicines. 2024 Aug 20;12(8):1911. doi: 10.3390/biomedicines12081911. PMID: 39200375; PMCID: PMC11352109.
Haensch CA, Tosch M, Katona I, Weis J, Isenmann S. Small-fiber neuropathy with cardiac denervation in postural tachycardia syndrome. Muscle Nerve. 2014 Dec;50(6):956-61. doi: 10.1002/mus.24245. Epub 2014 Aug 29. PMID: 24647968.
Bonyhay I, Freeman R. Sympathetic nerve activity in response to hypotensive stress in the postural tachycardia syndrome. Circulation. 2004 Nov 16;110(20):3193-8. doi: 10.1161/01.CIR.0000147280.90339.E9. Epub 2004 Nov 8. PMID: 15533861.
Zhang Q, Chen X, Li J, Du J. Orthostatic plasma norepinephrine level as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndrome. J Transl Med. 2014 Sep 10;12:249. doi: 10.1186/s12967-014-0249-3. PMID: 25204388; PMCID: PMC4177336.
Garland EM, Raj SR, Black BK, Harris PA, Robertson D. The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome. Neurology. 2007 Aug 21;69(8):790-8. doi: 10.1212/01.wnl.0000267663.05398.40. PMID: 17709712.
Sheldon RS, Grubb BP 2nd, Olshansky B, Shen WK, Calkins H, Brignole M, Raj SR, Krahn AD, Morillo CA, Stewart JM, Sutton R, Sandroni P, Friday KJ, Hachul DT, Cohen MI, Lau DH, Mayuga KA, Moak JP, Sandhu RK, Kanjwal K. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015 Jun;12(6):e41-63. doi: 10.1016/j.hrthm.2015.03.029. Epub 2015 May 14. PMID: 25980576; PMCID: PMC5267948.
Sebastian SA, Co EL, Panthangi V, Jain E, Ishak A, Shah Y, Vasavada A, Padda I. Postural Orthostatic Tachycardia Syndrome (POTS): An Update for Clinical Practice. Curr Probl Cardiol. 2022 Dec;47(12):101384. doi: 10.1016/j.cpcardiol.2022.101384. Epub 2022 Aug 31. PMID: 36055438.
Lin J, Han Z, Li X, Ochs T, Zhao J, Zhang X, Yang J, Liu P, Xiong Z, Gai Y, Tang C, Du J, Jin H. Risk factors for postural tachycardia syndrome in children and adolescents. PLoS One. 2014 Dec 4;9(12):e113625. doi: 10.1371/journal.pone.0113625. PMID: 25474569; PMCID: PMC4256207.
Mustafa HI, Garland EM, Biaggioni I, Black BK, Dupont WD, Robertson D, Raj SR. Abnormalities of angiotensin regulation in postural tachycardia syndrome. Heart Rhythm. 2011 Mar;8(3):422-8. doi: 10.1016/j.hrthm.2010.11.009. Epub 2011 Jan 22. PMID: 21266211; PMCID: PMC3050076.
Raj SR, Biaggioni I, Yamhure PC, Black BK, Paranjape SY, Byrne DW, Robertson D. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation. 2005 Apr 5;111(13):1574-82. doi: 10.1161/01.CIR.0000160356.97313.5D. Epub 2005 Mar 21. PMID: 15781744.
Stewart JM, Glover JL, Medow MS. Increased plasma angiotensin II in postural tachycardia syndrome (POTS) is related to reduced blood flow and blood volume. Clin Sci (Lond). 2006 Feb;110(2):255-63. doi: 10.1042/CS20050254. PMID: 16262605; PMCID: PMC4511483.
Ruzieh M, Baugh A, Dasa O, Parker RL, Perrault JT, Renno A, Karabin BL, Grubb B. Effects of intermittent intravenous saline infusions in patients with medication-refractory postural tachycardia syndrome. J Interv Card Electrophysiol. 2017 Apr;48(3):255-260. doi: 10.1007/s10840-017-0225-y. Epub 2017 Feb 9. PMID: 28185102.
Coffin ST, Black BK, Biaggioni I, Paranjape SY, Orozco C, Black PW, Dupont WD, Robertson D, Raj SR. Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome. Heart Rhythm. 2012 Sep;9(9):1484-90. doi: 10.1016/j.hrthm.2012.05.002. Epub 2012 May 3. PMID: 22561596; PMCID: PMC3419341.
Bryarly M, Phillips LT, Fu Q, Vernino S, Levine BD. Postural Orthostatic Tachycardia Syndrome: JACC Focus Seminar. J Am Coll Cardiol. 2019 Mar 19;73(10):1207-1228. doi: 10.1016/j.jacc.2018.11.059. PMID: 30871704.
Perhonen MA, Zuckerman JH, Levine BD. Deterioration of left ventricular chamber performance after bed rest : "cardiovascular deconditioning" or hypovolemia? Circulation. 2001 Apr 10;103(14):1851-7. doi: 10.1161/01.cir.103.14.1851. PMID: 11294802.
Perhonen MA, Franco F, Lane LD, Buckey JC, Blomqvist CG, Zerwekh JE, Peshock RM, Weatherall PT, Levine BD. Cardiac atrophy after bed rest and spaceflight. J Appl Physiol (1985). 2001 Aug;91(2):645-53. doi: 10.1152/jappl.2001.91.2.645. PMID: 11457776.
Gaffney FA, Nixon JV, Karlsson ES, Campbell W, Dowdey AB, Blomqvist CG. Cardiovascular deconditioning produced by 20 hours of bedrest with head-down tilt (-5 degrees) in middle-aged healthy men. Am J Cardiol. 1985 Oct 1;56(10):634-8. doi: 10.1016/0002-9149(85)91025-2. PMID: 4050700.
George SA, Bivens TB, Howden EJ, Saleem Y, Galbreath MM, Hendrickson D, Fu Q, Levine BD. The international POTS registry: Evaluating the efficacy of an exercise training intervention in a community setting. Heart Rhythm. 2016 Apr;13(4):943-50. doi: 10.1016/j.hrthm.2015.12.012. Epub 2015 Dec 9. PMID: 26690066.
Dahan S, Tomljenovic L, Shoenfeld Y. Postural Orthostatic Tachycardia Syndrome (POTS)--A novel member of the autoimmune family. Lupus. 2016 Apr;25(4):339-42. doi: 10.1177/0961203316629558. Epub 2016 Feb 3. PMID: 26846691.
Li H, Yu X, Liles C, Khan M, Vanderlinde-Wood M, Galloway A, Zillner C, Benbrook A, Reim S, Collier D, Hill MA, Raj SR, Okamoto LE, Cunningham MW, Aston CE, Kem DC. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc. 2014 Feb 26;3(1):e000755. doi: 10.1161/JAHA.113.000755. PMID: 24572257; PMCID: PMC3959717.
Fedorowski A, Li H, Yu X, Koelsch KA, Harris VM, Liles C, Murphy TA, Quadri SMS, Scofield RH, Sutton R, Melander O, Kem DC. Antiadrenergic autoimmunity in postural tachycardia syndrome. Europace. 2017 Jul 1;19(7):1211-1219. doi: 10.1093/europace/euw154. PMID: 27702852; PMCID: PMC5834103.
Shibao C, Arzubiaga C, Roberts LJ 2nd, Raj S, Black B, Harris P, Biaggioni I. Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension. 2005 Mar;45(3):385-90. doi: 10.1161/01.HYP.0000158259.68614.40. Epub 2005 Feb 14. PMID: 15710782.
Romero SA, McCord JL, Ely MR, Sieck DC, Buck TM, Luttrell MJ, MacLean DA, Halliwill JR. Mast cell degranulation and de novo histamine formation contribute to sustained postexercise vasodilation in humans. J Appl Physiol (1985). 2017 Mar 1;122(3):603-610. doi: 10.1152/japplphysiol.00633.2016. Epub 2016 Aug 25. PMID: 27562843; PMCID: PMC5401950.
Boris JR, Huang J, Shuey T, Bernadzikowski T. Family history of associated disorders in patients with postural tachycardia syndrome. Cardiol Young. 2020 Mar;30(3):388-394. doi: 10.1017/S1047951120000165. Epub 2020 Feb 3. Erratum in: Cardiol Young. 2020 Mar;30(3):395. doi: 10.1017/S1047951120000499. PMID: 32008600.
Jacob G, Shannon JR, Costa F, Furlan R, Biaggioni I, Mosqueda-Garcia R, Robertson RM, Robertson D. Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic intolerance. Circulation. 1999 Apr 6;99(13):1706-12. doi: 10.1161/01.cir.99.13.1706. PMID: 10190880.
Robertson D, Flattem N, Tellioglu T, Carson R, Garland E, Shannon JR, Jordan J, Jacob G, Blakely RD, Biaggioni I. Familial orthostatic tachycardia due to norepinephrine transporter deficiency. Ann N Y Acad Sci. 2001 Jun;940:527-43. doi: 10.1111/j.1749-6632.2001.tb03703.x. PMID: 11458707.
Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med. 2000 Feb 24;342(8):541-9. doi: 10.1056/NEJM200002243420803. PMID: 10684912.
Lambert E, Eikelis N, Esler M, Dawood T, Schlaich M, Bayles R, Socratous F, Agrotis A, Jennings G, Lambert G, Vaddadi G. Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with postural tachycardia syndrome. Circ Arrhythm Electrophysiol. 2008 Jun 1;1(2):103-9. doi: 10.1161/CIRCEP.107.750471. Epub 2008 Apr 30. PMID: 19808400.
Green EA, Raj V, Shibao CA, Biaggioni I, Black BK, Dupont WD, Robertson D, Raj SR. Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome. J Am Heart Assoc. 2013 Sep 3;2(5):e000395. doi: 10.1161/JAHA.113.000395. PMID: 24002370; PMCID: PMC3835251.
Fu Q, Witkowski S, Okazaki K, Levine BD. Effects of gender and hypovolemia on sympathetic neural responses to orthostatic stress. Am J Physiol Regul Integr Comp Physiol. 2005 Jul;289(1):R109-16. doi: 10.1152/ajpregu.00013.2005. Epub 2005 Mar 10. PMID: 15761188.
Peggs KJ, Nguyen H, Enayat D, Keller NR, Al-Hendy A, Raj SR. Gynecologic disorders and menstrual cycle lightheadedness in postural tachycardia syndrome. Int J Gynaecol Obstet. 2012 Sep;118(3):242-6. doi: 10.1016/j.ijgo.2012.04.014. Epub 2012 Jun 20. PMID: 22721633; PMCID: PMC3413773.
Antiel RM, Caudill JS, Burkhardt BE, Brands CK, Fischer PR. Iron insufficiency and hypovitaminosis D in adolescents with chronic fatigue and orthostatic intolerance. South Med J. 2011 Aug;104(8):609-11. doi: 10.1097/SMJ.0b013e3182246809. PMID: 21886073.
Hsiao HY , Chung CW , Santos JH , Villaflores OB , Lu TT . Fe in biosynthesis, translocation, and signal transduction of NO: toward bioinorganic engineering of dinitrosyl iron complexes into NO-delivery scaffolds for tissue engineering. Dalton Trans. 2019 Jul 2;48(26):9431-9453. doi: 10.1039/c9dt00777f. PMID: 30990502.
Choi JW, Pai SH, Kim SK, Ito M, Park CS, Cha YN. Iron deficiency anemia increases nitric oxide production in healthy adolescents. Ann Hematol. 2002 Jan;81(1):1-6. doi: 10.1007/s00277-001-0409-4. Epub 2001 Dec 13. PMID: 11807627.
Jarjour IT, Jarjour LK. Low iron storage and mild anemia in postural tachycardia syndrome in adolescents. Clin Auton Res. 2013 Aug;23(4):175-9. doi: 10.1007/s10286-013-0198-6. Epub 2013 May 30. PMID: 23720007.
Lu W, Yan H, Wu S, Xu W, Jin H, Du J. Hemocytometric Measures Predict the Efficacy of Oral Rehydration for Children with Postural Tachycardia Syndrome. J Pediatr. 2017 Aug;187:220-224. doi: 10.1016/j.jpeds.2017.04.034. Epub 2017 May 16. PMID: 28526222.
Shaw BH, Stiles LE, Bourne K, Green EA, Shibao CA, Okamoto LE, Garland EM, Gamboa A, Diedrich A, Raj V, Sheldon RS, Biaggioni I, Robertson D, Raj SR. The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey. J Intern Med. 2019 Oct;286(4):438-448. doi: 10.1111/joim.12895. Epub 2019 Apr 16. PMID: 30861229; PMCID: PMC6790699.
Pohlgeers KM, Stumbo JR. Syncope in an Athlete: a Case of Infectious Mononucleosis-Induced Postural Tachycardia Syndrome. Curr Sports Med Rep. 2016 Jan-Feb;15(1):41-5. doi: 10.1249/JSR.0000000000000227. PMID: 26745170.
Yaxley KL. Infectious mononucleosis complicated by peritonsillar abscess and postural orthostatic tachycardia syndrome: A case report. SAGE Open Med Case Rep. 2020 Apr 2;8:2050313X20915413. doi: 10.1177/2050313X20915413. PMID: 32284866; PMCID: PMC7139175.
Goldstein DS. The possible association between COVID-19 and postural tachycardia syndrome. Heart Rhythm. 2021 Apr;18(4):508-509. doi: 10.1016/j.hrthm.2020.12.007. Epub 2020 Dec 11. PMID: 33316414; PMCID: PMC7729277.
Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn DI, Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clin Auton Res. 2020 Oct;30(5):449-451. doi: 10.1007/s10286-020-00727-9. Epub 2020 Sep 3. PMID: 32880754; PMCID: PMC7471493.
Blitshteyn S, Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. 2021 Apr;69(2):205-211. doi: 10.1007/s12026-021-09185-5. Epub 2021 Mar 30. Erratum in: Immunol Res. 2021 Apr;69(2):212. doi: 10.1007/s12026-021-09191-7. PMID: 33786700; PMCID: PMC8009458.
Busatto GF, de Araújo AL, Duarte AJDS, Levin AS, Guedes BF, Kallas EG, Pinna FR, de Souza HP, da Silva KR, Sawamura MVY, Seelaender M, Imamura M, Garcia ML, Forlenza OV, Nitrini R, Damiano RF, Rocha VG, Batisttella LR, Carvalho CRR; HCFMUSP PASC Initiative; HCFMUSP Covid-19 Study Group. Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil. BMJ Open. 2021 Jun 30;11(6):e051706. doi: 10.1136/bmjopen-2021-051706. PMID: 34193506; PMCID: PMC8249176.
Altmann DM, Whettlock EM, Liu S, Arachchillage DJ, Boyton RJ. The immunology of long COVID. Nat Rev Immunol. 2023 Oct;23(10):618-634. doi: 10.1038/s41577-023-00904-7. Epub 2023 Jul 11. Erratum in: Nat Rev Immunol. 2023 Oct;23(10):697. doi: 10.1038/s41577-023-00948-9. PMID: 37433988.
Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, Lim PB. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clin Med (Lond). 2021 Jan;21(1):e63-e67. doi: 10.7861/clinmed.2020-0896. Epub 2020 Nov 26. PMID: 33243837; PMCID: PMC7850225.
El-Rhermoul FZ, Fedorowski A, Eardley P, Taraborrelli P, Panagopoulos D, Sutton R, Lim PB, Dani M. Autoimmunity in Long Covid and POTS. Oxf Open Immunol. 2023 Mar 8;4(1):iqad002. doi: 10.1093/oxfimm/iqad002. PMID: 37255928; PMCID: PMC10224806.
Hansen IS, Baeten DLP, den Dunnen J. The inflammatory function of human IgA. Cell Mol Life Sci. 2019 Mar;76(6):1041-1055. doi: 10.1007/s00018-018-2976-8. Epub 2018 Nov 29. PMID: 30498997; PMCID: PMC6513800.
Yu HQ, Sun BQ, Fang ZF, Zhao JC, Liu XY, Li YM, Sun XZ, Liang HF, Zhong B, Huang ZF, Zheng PY, Tian LF, Qu HQ, Liu DC, Wang EY, Xiao XJ, Li SY, Ye F, Guan L, Hu DS, Hakonarson H, Liu ZG, Zhong NS. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients. Eur Respir J. 2020 Aug 27;56(2):2001526. doi: 10.1183/13993003.01526-2020. PMID: 32398307; PMCID: PMC7236821.
Wang EY, Chen H, Sun BQ, Wang H, Qu HQ, Liu Y, Sun XZ, Qu J, Fang ZF, Tian L, Zeng YF, Huang SK, Hakonarson H, Liu ZG. Serum levels of the IgA isotype switch factor TGF-β1 are elevated in patients with COVID-19. FEBS Lett. 2021 Jul;595(13):1819-1824. doi: 10.1002/1873-3468.14104. Epub 2021 May 21. Erratum in: FEBS Lett. 2021 Nov;595(22):2844. doi: 10.1002/1873-3468.14217. PMID: 33961290; PMCID: PMC8209884.
Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology. 1993 Jan;43(1):132-7. doi: 10.1212/wnl.43.1_part_1.132. PMID: 8423877.
Raj SR, Guzman JC, Harvey P, Richer L, Schondorf R, Seifer C, Thibodeau-Jarry N, Sheldon RS. Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance. Can J Cardiol. 2020 Mar;36(3):357-372. doi: 10.1016/j.cjca.2019.12.024. PMID: 32145864.
Wieling W, Krediet CT, van Dijk N, Linzer M, Tschakovsky ME. Initial orthostatic hypotension: review of a forgotten condition. Clin Sci (Lond). 2007 Feb;112(3):157-65. doi: 10.1042/CS20060091. PMID: 17199559.
Arnold AC, Ng J, Raj SR. Postural tachycardia syndrome - Diagnosis, physiology, and prognosis. Auton Neurosci. 2018 Dec;215:3-11. doi: 10.1016/j.autneu.2018.02.005. Epub 2018 Feb 28. PMID: 29523389; PMCID: PMC6113123.
Plash WB, Diedrich A, Biaggioni I, Garland EM, Paranjape SY, Black BK, Dupont WD, Raj SR. Diagnosing postural tachycardia syndrome: comparison of tilt testing compared with standing haemodynamics. Clin Sci (Lond). 2013 Jan;124(2):109-14. doi: 10.1042/CS20120276. PMID: 22931296; PMCID: PMC3478101.
Brewster JA, Garland EM, Biaggioni I, Black BK, Ling JF, Shibao CA, Robertson D, Raj SR. Diurnal variability in orthostatic tachycardia: implications for the postural tachycardia syndrome. Clin Sci (Lond). 2012 Jan;122(1):25-31. doi: 10.1042/CS20110077. PMID: 21751966; PMCID: PMC3172399.
Goodman BP. Evaluation of postural tachycardia syndrome (POTS). Auton Neurosci. 2018 Dec;215:12-19. doi: 10.1016/j.autneu.2018.04.004. Epub 2018 Apr 22. PMID: 29705015.
Kizilbash SJ, Ahrens SP, Bruce BK, Chelimsky G, Driscoll SW, Harbeck-Weber C, Lloyd RM, Mack KJ, Nelson DE, Ninis N, Pianosi PT, Stewart JM, Weiss KE, Fischer PR. Adolescent fatigue, POTS, and recovery: a guide for clinicians. Curr Probl Pediatr Adolesc Health Care. 2014 May-Jun;44(5):108-33. doi: 10.1016/j.cppeds.2013.12.014. PMID: 24819031; PMCID: PMC5819886.
Fedorowski A, Melander O. Syndromes of orthostatic intolerance: a hidden danger. J Intern Med. 2013 Apr;273(4):322-35. doi: 10.1111/joim.12021. PMID: 23216860.
Raj SR, Coffin ST. Medical therapy and physical maneuvers in the treatment of the vasovagal syncope and orthostatic hypotension. Prog Cardiovasc Dis. 2013 Jan-Feb;55(4):425-33. doi: 10.1016/j.pcad.2012.11.004. PMID: 23472781; PMCID: PMC3594734.
van Dijk N, de Bruin IG, Gisolf J, de Bruin-Bon HA, Linzer M, van Lieshout JJ, Wieling W. Hemodynamic effects of leg crossing and skeletal muscle tensing during free standing in patients with vasovagal syncope. J Appl Physiol (1985). 2005 Feb;98(2):584-90. doi: 10.1152/japplphysiol.00738.2004. Epub 2004 Oct 8. PMID: 15475601.
Winker R, Barth A, Bidmon D, Ponocny I, Weber M, Mayr O, Robertson D, Diedrich A, Maier R, Pilger A, Haber P, Rüdiger HW. Endurance exercise training in orthostatic intolerance: a randomized, controlled trial. Hypertension. 2005 Mar;45(3):391-8. doi: 10.1161/01.HYP.0000156540.25707.af. Epub 2005 Feb 7. PMID: 15699447.
Galbreath MM, Shibata S, VanGundy TB, Okazaki K, Fu Q, Levine BD. Effects of exercise training on arterial-cardiac baroreflex function in POTS. Clin Auton Res. 2011 Apr;21(2):73-80. doi: 10.1007/s10286-010-0091-5. Epub 2010 Nov 20. PMID: 21103906.
Fu Q, Vangundy TB, Galbreath MM, Shibata S, Jain M, Hastings JL, Bhella PS, Levine BD. Cardiac origins of the postural orthostatic tachycardia syndrome. J Am Coll Cardiol. 2010 Jun 22;55(25):2858-68. doi: 10.1016/j.jacc.2010.02.043. PMID: 20579544; PMCID: PMC2914315.
Shibata S, Fu Q, Bivens TB, Hastings JL, Wang W, Levine BD. Short-term exercise training improves the cardiovascular response to exercise in the postural orthostatic tachycardia syndrome. J Physiol. 2012 Aug 1;590(15):3495-505. doi: 10.1113/jphysiol.2012.233858. Epub 2012 May 28. PMID: 22641777; PMCID: PMC3547265.
Gibbons CH, Silva G, Freeman R. Cardiovascular exercise as a treatment of postural orthostatic tachycardia syndrome: A pragmatic treatment trial. Heart Rhythm. 2021 Aug;18(8):1361-1368. doi: 10.1016/j.hrthm.2021.01.017. Epub 2021 Jan 19. PMID: 33482385.
Smit AA, Wieling W, Fujimura J, Denq JC, Opfer-Gehrking TL, Akarriou M, Karemaker JM, Low PA. Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunction. Clin Auton Res. 2004 Jun;14(3):167-75. doi: 10.1007/s10286-004-0187-x. PMID: 15241645.
Podoleanu C, Maggi R, Brignole M, Croci F, Incze A, Solano A, Puggioni E, Carasca E. Lower limb and abdominal compression bandages prevent progressive orthostatic hypotension in elderly persons: a randomized single-blind controlled study. J Am Coll Cardiol. 2006 Oct 3;48(7):1425-32. doi: 10.1016/j.jacc.2006.06.052. Epub 2006 Sep 14. PMID: 17010806.
Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, Fedorowski A, Furlan R, Kenny RA, Martín A, Probst V, Reed MJ, Rice CP, Sutton R, Ungar A, van Dijk JG; ESC Scientific Document Group. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018 Jun 1;39(21):1883-1948. doi: 10.1093/eurheartj/ehy037. PMID: 29562304.
Wells R, Elliott AD, Mahajan R, Page A, Iodice V, Sanders P, Lau DH. Efficacy of Therapies for Postural Tachycardia Syndrome: A Systematic Review and Meta-analysis. Mayo Clin Proc. 2018 Aug;93(8):1043-1053. doi: 10.1016/j.mayocp.2018.01.025. Epub 2018 Jun 21. PMID: 29937049.
Miller AJ, Raj SR. Pharmacotherapy for postural tachycardia syndrome. Auton Neurosci. 2018 Dec;215:28-36. doi: 10.1016/j.autneu.2018.04.008. Epub 2018 May 4. PMID: 29753556.
Lai CC, Fischer PR, Brands CK, Fisher JL, Porter CB, Driscoll SW, Graner KK. Outcomes in adolescents with postural orthostatic tachycardia syndrome treated with midodrine and beta-blockers. Pacing Clin Electrophysiol. 2009 Feb;32(2):234-8. doi: 10.1111/j.1540-8159.2008.02207.x. PMID: 19170913.
Wyller VB, Thaulow E, Amlie JP. Treatment of chronic fatigue and orthostatic intolerance with propranolol. J Pediatr. 2007 Jun;150(6):654-5. doi: 10.1016/j.jpeds.2007.03.012. PMID: 17517256.
Cappato R, Castelvecchio S, Ricci C, Bianco E, Vitali-Serdoz L, Gnecchi-Ruscone T, Pittalis M, De Ambroggi L, Baruscotti M, Gaeta M, Furlanello F, Di Francesco D, Lupo PP. Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation. J Am Coll Cardiol. 2012 Oct 9;60(15):1323-9. doi: 10.1016/j.jacc.2012.06.031. Epub 2012 Sep 12. PMID: 22981555.
McDonald C, Frith J, Newton JL. Single centre experience of ivabradine in postural orthostatic tachycardia syndrome. Europace. 2011 Mar;13(3):427-30. doi: 10.1093/europace/euq390. Epub 2010 Nov 9. PMID: 21062792; PMCID: PMC3043639.
Ruzieh M, Sirianni N, Ammari Z, Dasa O, Alhazmi L, Karabin B, Grubb B. Ivabradine in the treatment of postural tachycardia syndrome (POTS), a single center experience. Pacing Clin Electrophysiol. 2017 Nov;40(11):1242-1245. doi: 10.1111/pace.13182. Epub 2017 Sep 20. PMID: 28846151.
Barzilai M, Jacob G. The Effect of Ivabradine on the Heart Rate and Sympathovagal Balance in Postural Tachycardia Syndrome Patients. Rambam Maimonides Med J. 2015 Jul 30;6(3):e0028. doi: 10.5041/RMMJ.10213. PMID: 26241226; PMCID: PMC4524401.
McDonald C, Koshi S, Busner L, Kavi L, Newton JL. Postural tachycardia syndrome is associated with significant symptoms and functional impairment predominantly affecting young women: a UK perspective. BMJ Open. 2014 Jun 16;4(6):e004127. doi: 10.1136/bmjopen-2013-004127. PMID: 24934205; PMCID: PMC4067814.
Kanjwal K, Karabin B, Sheikh M, Elmer L, Kanjwal Y, Saeed B, Grubb BP. Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience. Pacing Clin Electrophysiol. 2011 Jun;34(6):750-5. doi: 10.1111/j.1540-8159.2011.03047.x. Epub 2011 Mar 16. PMID: 21410722.
Gales BJ, Gales MA. Pyridostigmine in the treatment of orthostatic intolerance. Ann Pharmacother. 2007 Feb;41(2):314-8. doi: 10.1345/aph.1H458. Epub 2007 Feb 6. PMID: 17284509.
Ross AJ, Ocon AJ, Medow MS, Stewart JM. A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic compared with hyperadrenergic postural tachycardia syndrome. Clin Sci (Lond). 2014 Feb;126(4):289-96. doi: 10.1042/CS20130222. PMID: 23978222; PMCID: PMC3896075.
Chen L, Wang L, Sun J, Qin J, Tang C, Jin H, Du J. Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycardia syndrome. Circ J. 2011;75(4):927-31. doi: 10.1253/circj.cj-10-0514. Epub 2011 Feb 2. PMID: 21301135.
Lai CC, Fischer PR, Brands CK, Fisher JL, Porter CB, Driscoll SW, Graner KK. Outcomes in adolescents with postural orthostatic tachycardia syndrome treated with midodrine and beta-blockers. Pacing Clin Electrophysiol. 2009 Feb;32(2):234-8. doi: 10.1111/j.1540-8159.2008.02207.x. PMID: 19170913.
Fagermoen E, Sulheim D, Winger A, Andersen AM, Gjerstad J, Godang K, Rowe PC, Saul JP, Skovlund E, Wyller VB. Effects of low-dose clonidine on cardiovascular and autonomic variables in adolescents with chronic fatigue: a randomized controlled trial. BMC Pediatr. 2015 Sep 10;15:117. doi: 10.1186/s12887-015-0428-2. PMID: 26357864; PMCID: PMC4566847.
Freitas J, Santos R, Azevedo E, Costa O, Carvalho M, de Freitas AF. Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone. Clin Auton Res. 2000 Oct;10(5):293-9. doi: 10.1007/BF02281112. PMID: 11198485.
Coffin ST, Black BK, Biaggioni I, Paranjape SY, Orozco C, Black PW, Dupont WD, Robertson D, Raj SR. Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome. Heart Rhythm. 2012 Sep;9(9):1484-90. doi: 10.1016/j.hrthm.2012.05.002. Epub 2012 May 3. PMID: 22561596; PMCID: PMC3419341.
Moak JP, Leong D, Fabian R, Freedenberg V, Jarosz E, Toney C, Hanumanthaiah S, Darbari A. Intravenous Hydration for Management of Medication-Resistant Orthostatic Intolerance in the Adolescent and Young Adult. Pediatr Cardiol. 2016 Feb;37(2):278-82. doi: 10.1007/s00246-015-1274-6. Epub 2015 Oct 7. PMID: 26446285.
Figueroa RA, Arnold AC, Nwazue VC, Okamoto LE, Paranjape SY, Black BK, Diedrich A, Robertson D, Biaggioni I, Raj SR, Gamboa A. Acute volume loading and exercise capacity in postural tachycardia syndrome. J Appl Physiol (1985). 2014 Sep 15;117(6):663-8. doi: 10.1152/japplphysiol.00367.2014. Epub 2014 Jul 24. PMID: 25059240; PMCID: PMC4157162.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Alicja Dziedzic, Daria Furtak, Wiktor Grela, Jagoda Niewiadomska, Paulina Głogowska, Dawid Tulej, Dominika Marciniuk, Natalia Gniaź, Aleksandra Górska, Natalia Marko
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 12
Number of citations: 0